Aerie Pharmaceuticals Inc. (AERI)

20.51
NASDAQ : Health Technology
Prev Close 21.25
Day Low/High 19.97 / 21.42
52 Wk Low/High 17.51 / 60.05
Avg Volume 1.27M
Exchange NASDAQ
Shares Outstanding 45.94M
Market Cap 976.20M
EPS -5.60
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Aerie Pharmaceuticals Has Broken Out on the Upside

Aerie Pharmaceuticals Has Broken Out on the Upside

Let's review the latest charts and indicators to see where we can get positioned from the long side.

Flexion Shares Lower After Proposed Stock Offering -- Biotech Movers

Flexion Shares Lower After Proposed Stock Offering -- Biotech Movers

The Burlington, Mass.-based firm announced a proposed public offering of 4 million shares. It plans to use part of the net proceeds to fund manufacturing and commercialization of osteoarthritis knee pain treatment Zilretta.

My Takeaways and Observations

"I'd unravel every riddle for any individ'le, In trouble or in pain. With the thoughts I'd be thinkin' I could be another Lincoln If I only had a brain." -- "If I Only Had A Brain" (Harold Arlen and E.Y. Harburg), from "The Wizard of Oz" I believe I...

Biowreck!

I am not sure if this has broader consequences, but biotech (especially of a speculative -- kind) is spitting the bit, again today.   I have already mentioned Allergan AGN (which I am buying now). Celgene CELG and Gilead Sciences GILD can't rally ei...

Takeaways and Observations

"She's a witch of trouble in electric blue, In her own mad mind she's in love with you. With you. Now what you gonna do? Strange brew, kill what's inside of you." -- Cream, Strange Brew     Strange brew!    You have probably forgotten October, 1987....

Added to Allergan on Weakness

Allergan , a day ahead of its earnings release, is down by over $4 on no apparent news, save a rotation out of biotech. (iShares Nasdaq Biotechnology is -3% or -$7 and we see individual equity declines in Celgene , Gilead , Acadia Pharmaceuticals , ...

The Good, the Bad and the Ugly (Late Afternoon Edition)

"It's not a joke, it's a rope, Tuco. Now I want you to get up there and put your head in that noose." -- Blondie, " The Good, the Bad and the Ugly" No "Takeaways" today as I have I might be trading some of the earnings reports that will be released ...

Takeaways and Observations

"I understand that there's a certain comfort in crowds, as well as a distrust of the remnants of individual opinion. I suppose that's a function of the human condition, human spirit and human nature." -- Kass Diary, "You Gotta Be in It To Win It?"  ...

Some Midday Observations

"Every little swallow, every chick-a-dee Every little bird in the tall oak tree The wise old owl, the big black crow Flappin' their wings signin' "go bird, go" Rockin' robin, (tweet-tweet-tweet) Rock-rock-rockin' robin' (tweet-tweedilly-tweet) Go ro...

Takeaways & Observations

Risk happens fast.  Most don't short and shouldn't short -- it's a game that requires volumes of risk control.  However, I would continue to maintain well above-average cash positions.  Today was not a benign event, in my view.  Nor was it likely a ...

Takeaways & Observations

I wanted to start by congratulating El Capitan for his 12th anniversary for Mad Money tonight. Like the Energizer Bunny, he keeps going and going...  HIgh yield gets junky -- despite protestations from Merrill's junk department! I have been warning ...

4 Small-Cap Biotech Stars

4 Small-Cap Biotech Stars

I'm still enthusiastic about the sector, but it is critical to also be prudent.

4 Small-Cap Biotech Stars

4 Small-Cap Biotech Stars

I'm still enthusiastic about the sector, but it is critical to also be prudent.

My Takeaways and Observatons

"As to the markets, it trades like participants are sleeping off hangovers from partying hard during last night's Super Bowl thriller." -- "Is Another Lesson Soon to be Learned?"   With such little price action it seemed like a snore fest (see above...

My Takeaways and Observations

Risk happens fast.    Is the presidential honeymoon over? One of the 10 questions I asked myself today.    "The Return of the Orange Swan?"    Has Boca Biff done it again? Another top call?    Ten questions. In particular, read my comments on Steve ...

Dearth of Momentum Helps Build 'Wall of Worry'

Dearth of Momentum Helps Build 'Wall of Worry'

Despite sluggishness, bears are not able to produce any real selling pressure.

My Takeaways and Observations (Early Edition)

I had my most active day of the year trading. It was also my most profitable.   Regardless of one's market view, I continue to see more opportunities on the trading side vs. the investing side in the months ahead.   I started the day with a story re...

The Good, the Bad and the Ugly in Today's Trading (Early Afternoon Edition)

"You see, in this world there's two kinds of people, my friend: Those with loaded guns and those who dig. You dig." -- Blondie, " The Good, the Bad and the Ugly" Here's a quick review of today's market action at 2 pm: The Good Bonds and bond-equival...

My Takeaways and Observations

I have a series of meetings this afternoon and tomorrow morning so I want to get "Takeaways" out early today. I started with what I think is an important opening missive, "Wary in an Uncertain World" in which I covered a number of bases. I truly bel...

Inotek Pharma Shares Plummet Following Negative Glaucoma Trial Results

Inotek Pharma Shares Plummet Following Negative Glaucoma Trial Results

Shares of Inotek Pharma plummeted Tuesday after saying that its Phase 3 clinical trial for the treatment of glaucoma did not "achieve superiority to the placebo."

My Takeaways and Observations

"Everyone here likes the bounce." -- President-elect Donald Trump (said in a meeting today at Trump Tower with tech executives) A good day for the ursine crowd but not so good for the bullish cabal as they had a bad day -- for a change. (Yes, I am w...

My Takeaways and Observations (3:30 p.m. Edition)

It may be time to embrace the contrary.    First issue (!!): The Palm Beach Chronicles.   My weekly (brief) technical review of the markets -- cooling off ahead?    BTIG's Stockton is bullish and so, as I have expressed, are most others!   Campbell ...

Retail, Financials, Speculative Biotechs Getting Hit

This morning I warned about an overbought group of market sectors/leaders.   Thus far, (recent leaders) retail and financials are being taken out to the woodshed.   Speculative biotech, like Intrexon  , Portola Pharmaceuticals  , SAGE Therapeutics  ...

The Good, the Bad and the Ugly

"If you work for a living, why the hell do you kill yourself working?" -- Tuco the Ugly" The Good, the Bad and the Ugly" I further added to my short exposure today in a quiet, pre-Thanksgiving trading session. And now it's time to run down "The Good...

The Good, the Bad and the Ugly (2:30 PM Edition)

"If you work for a living, why the hell do you kill yourself working?" -- Tuco the Ugly "The Good, the Bad and the Ugly" I did only a small amount of trading today (and added to short exposure), and there will be no "Takeaways" today (it's family ti...

My Takeaways and Observations

At the end of the day!    Don't run with the crowd: Embrace contrary and second-level thinking instead.    Extreme policy uncertainty.    More Howard Marks.    Less Bill Miller.    My little sister!    Graf wrote a goodie.    The movie was in revers...

My Takeaways and Observations

"Dougie, take what Mr. Market gives you." -- Grandma Koufax And I did, Grandma Koufax.   A consecutive nine-day market drop was snapped as we regained most that was lost in that period.   Today was a great day. (Boy, would I like to annualize the pe...

My Takeaways and Observations (Early Edition)

I have been warning about weakening breadth and narrow leadership for weeks and months.   What have we gotten? Eight straight days (in a row) down for the first time since 2008.   But, with stocks suffering from election uncertainties and given the ...